BSECompany Update1h ago · 22 Jul 2026, 06:42 pm
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Medplus Health Services Ltd · 543427
✦ AI Summary▼ NegativeRegulatory
Medplus Health Services Ltd's subsidiary, Optival Health Solutions Private Limited, has received three suspension orders for drug licenses at stores in Karnataka, resulting in potential revenue loss of Rs 0.49 lacs, Rs 0.12 lacs, and Rs 0.42 lacs for two and one day respectively.
Analysis Scores
Earnings Impact2/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk8/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment2/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Medplus Health Services Ltd - 543427 - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Attachments (1)
📄pdf
Download →
a7460808-419f-4fca-80bc-6b927c7961dd.pdf
View document text
MedPlus Health Services Limited
July 22, 2026
The Listing Department The Listing Department
BSE Limited N ational Stock Exchange of India Limited
Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor
Dalal Street, Fort, Plot No. C/1, G Block,
Mumbai – 400001 Bandra - Kurla Complex
BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051
NSE Symbol: MEDPLUS
Dear Sir/Madam,
Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015
We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has
received three suspension orders for a Drug License of a store situated in the state mentioned below:
Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD
POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows:
Name(s) of the Authority Nature and details of the Date of receipt of Details of the Impact on
action(s) taken, initiated direction or order, violation(s)/ financial
or order(s) passed including any contravention(s) operation or
interim or interim committed or alleged other activities of
orders, or any to be committed the listed entity,
other quantifiable in
communication monetary terms
from the to the extent
authority possible
Suspension of Drug Potential Revenue
License for two days of Loss of Rs 0.49
store situated at New lacs.
Ksrtc Layout Athani
Assistant Director, Drugs Road, Karnataka.
Control Administration,
Vijayapura Circle, Suspension of Drug Potential Revenue
Under Rule 65 of
Vijayapura, Karnataka. License for one day of Loss of Rs 0.12
Order received on Drugs and Cosmetics
store situated at Adarsha lacs.
21.07.2026 Act, 1940 and Drugs
Nagar Vijayapura,
and Cosmetics Rules,
Karnataka.
1945
Assistant Director, Drugs Suspension of Drug Potential Revenue
Control Administration License for two days of Loss of Rs 0.42
Chikkaballapura Circle, store situated at lacs.
Chikkaballapura, Chinthamani Bangalore
Karnataka. Road, Karnataka.
The same will be available on the website of the Company at www.medplusindia.com and also on the websites
of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com
respectively. Kindly take the same on records.
For MedPlus Health Services Limited
Shrenik Soni
Company Secretary & Compliance Officer
040-6724 672
Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India
CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com